These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16741899)

  • 41. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
    Inal MT; Memiş D; Kargi M; Sut N
    J Crit Care; 2009 Sep; 24(3):329-34. PubMed ID: 19327336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients.
    Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB
    Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
    Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
    Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporary silastic mesh closure for adult liver transplantation: a safe alternative for the difficult abdomen.
    Jafri MA; Tevar AD; Lucia M; Thambi-Pillai T; Karachristos A; Trumbull L; Buell JF; Thomas MJ; Hanaway MJ; Woodle ES; Rudich SM
    Liver Transpl; 2007 Feb; 13(2):258-65. PubMed ID: 17256756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.
    Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS
    Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of plasmapheresis and molecular adsorbent recirculating system efficacy in graft failure after living donor liver transplantation.
    Ince V; Aydin C; Otan E; Karabulut K; Koc S; Kayaalp C; Yilmaz S
    Transplant Proc; 2013 Apr; 45(3):971-3. PubMed ID: 23622601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation.
    Fábrega E; Orive A; García-Unzueta M; Amado JA; Casafont F; Pons-Romero F
    Clin Transplant; 2006; 20(3):383-8. PubMed ID: 16824158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients.
    Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
    Transpl Int; 2008 Sep; 21(9):857-66. PubMed ID: 18510596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
    Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
    Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Early risk factors of acute lung injury following orthotopic liver transplantation].
    Li SR; Shen N; Hei ZQ
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3049-52. PubMed ID: 19192404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indocyanine green disappearance rate is the most useful marker for liver resection.
    Scheingraber S; Richter S; Igna D; Flesch S; Kopp B; Schilling MK
    Hepatogastroenterology; 2008; 55(85):1394-9. PubMed ID: 18795697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MARS dialysis in decompensated alcoholic liver disease: a single-center experience.
    Wolff B; Machill K; Schumacher D; Schulzki I
    Liver Transpl; 2007 Aug; 13(8):1189-92. PubMed ID: 17663393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular adsorbent recycling system in treating patients with acute liver failure: a bridge to liver transplantation.
    Ding YT; Xu QX; Qiu YD; Yang YJ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):508-10. PubMed ID: 15567734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports.
    Pugliese F; Ruberto F; Perrella SM; Cappannoli A; Bruno K; Martelli S; Celli P; Summonti D; D'Alio A; Tosi A; Novelli G; Morabito V; Poli L; Rossi M; Berloco PB; Pietropaoli P
    Transplant Proc; 2007; 39(6):2042-4. PubMed ID: 17692688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration.
    Liu YH; Wang Y; Yu LX; Sun LY; Feng BL; Shen ZY; Wang MM
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):316-7. PubMed ID: 15138135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transplantation: impact of pretransplant renal insufficiency.
    Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
    Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
    Novelli G; Rossi M; Pugliese F; Poli I; Ruberto E; Martelli S; Nudo F; Morabito V; Mennini G; Berloco PB
    Transplant Proc; 2007; 39(6):1864-7. PubMed ID: 17692635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation.
    Soliman T; Hetz H; Burghuber C; Györi G; Silberhumer G; Steininger R; Mühlbacher F; Berlakovich GA
    Liver Transpl; 2007 Jul; 13(7):1039-44. PubMed ID: 17600336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A single-center experience of retransplantation for liver transplant recipients with a failing graft.
    Chen GH; Fu BS; Cai CJ; Lu MQ; Yang Y; Yi SH; Xu C; Li H; Wang GS; Zhang T
    Transplant Proc; 2008 Jun; 40(5):1485-7. PubMed ID: 18589134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.